(Q34106787)

31 July 2017

1 reference

title

Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment (English)

1 reference

31 July 2017

Zhou Q

1

1 reference

31 July 2017

Hopp T

series ordinal

2

1 reference

31 July 2017

Fuqua SA

series ordinal

3

1 reference

31 July 2017

Steeg PS

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

162

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

3-17

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclins and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclins, cyclin-dependent kinases and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

1 reference

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Risk factors for breast cancer in women with proliferative breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Radial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Anatomic markers of human premalignancy and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

The influence of margin width on local control of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Microvessel density and distribution in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Nm23 protein expression in ductal in situ and invasive human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cell-cycle inhibitors: three families united by a common cause

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Rb function in cell-cycle regulation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Physical interaction of the retinoblastoma protein with human D cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

CDK-independent activation of estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 is an essential mediator of apoptotic neuronal cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Balance of cell proliferation and apoptosis in breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Preclinical and clinical development of cyclin-dependent kinase modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Retinoids in cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Role of retinoid receptors in the prevention and treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Chemoprevention: general perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

Cancer chemoprevention: progress and promise

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900657-1

7 January 2021

10.1016/S0304-3835(00)00657-1

Identifiers

DOI

1 reference

release_7y3hwek6kjehhf6ube5xpzasju

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7y3hwek6kjehhf6ube5xpzasju

24 November 2022

mapped directly with Wikidata item

1 reference